Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Russia projects budget deficit under optimistic scenario

    September 19, 2026

    Global Gender Parity Stalls as Economic Growth Faces Sudden Slowdown

    September 19, 2026

    Bank of England Plans to Phase Out Gilt Holdings by 2034

    September 18, 2026
    Trending
    • Russia projects budget deficit under optimistic scenario
    • Global Gender Parity Stalls as Economic Growth Faces Sudden Slowdown
    • Bank of England Plans to Phase Out Gilt Holdings by 2034
    • Apple Launches Its First Foldable Smartphone with the iPhone Duo
    • Bank of England Reviews September Rate and Bond Policies
    • First Bird Flu Fatality Among Endangered Australian Sea Lions Reported on Kangaroo Island
    • OeNB Revises Down Austria’s 2026 Growth Forecast and Raises 2027 Outlook
    • Gold Approaches Its Lowest Level in a Week as Spot Prices Decline
    • Home
    • Contact Us
    Buckingham DailyBuckingham Daily
    Sunday, September 20
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Buckingham DailyBuckingham Daily
    Home » Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s
    Health

    Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s

    November 22, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    In the relentless battle against neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s, a groundbreaking discovery emerges from The University of Texas at El Paso. Researchers, exploring the unlikeliest of sources—spent coffee grounds—have unearthed a potential weapon against these debilitating conditions that afflict millions and strain healthcare budgets with hundreds of billions in annual costs.

    Brewing hope - how used coffee grounds may combat Alzheimer's and Parkinson's

    Leading the charge is Jyotish Kumar, a doctoral student in the Department of Chemistry and Biochemistry, along with Mahesh Narayan, Ph.D., a distinguished professor and Royal Society of Chemistry Fellow. Their team has identified caffeic-acid based Carbon Quantum Dots (CACQDs), derivable from used coffee grounds, as a promising agent in shielding brain cells from damage typically associated with neurodegenerative diseases, particularly those exacerbated by factors like obesity, aging, and exposure to environmental toxins.

    Their findings, detailed in the journal Environmental Research, mark a significant leap forward. “CACQDs could revolutionize neurodegenerative disease treatment,” Kumar states. Unlike existing therapies that merely manage symptoms, CACQDs aim at the root causes – the molecular triggers of these ailments. Neurodegenerative diseases, characterized by neuron loss, impair basic and complex functions—from movement and speech to cognitive abilities.

    Lifestyle and environmental factors in early stages of these diseases often lead to increased free radicals and amyloid protein fragment aggregation in the brain, contributing to the progression of these conditions. Kumar’s team discovered that CACQDs offer neuroprotection in various models of Parkinson’s disease, particularly those induced by the pesticide paraquat. The CACQDs demonstrated an ability to neutralize free radicals and prevent amyloid protein aggregation, all without notable side effects.

    This breakthrough suggests that early intervention with CACQD-based treatments could thwart the full onset of diseases like Alzheimer’s and Parkinson’s. Caffeic acid, a polyphenol known for its antioxidant properties, is uniquely capable of crossing the blood-brain barrier, thus directly impacting brain cells. The team’s “green chemistry” approach to extracting CACQDs from coffee waste—cooking grounds at 200° for four hours—is both eco-friendly and cost-effective, making this a sustainable solution.

    The project, encompassing contributions from numerous UTEP graduate and undergraduate students, including Sofia Delgado, now a Ph.D. student at Yale University, signifies a collective effort in scientific advancement. While Narayan and Kumar acknowledge the journey ahead is long, the potential of developing a simple, pill-based preventative treatment for the majority of non-genetically caused neurodegenerative disorders remains a beacon of hope.

    Related Posts

    EU Sees Obesity Rate Rise to 16.3%, Over Half Are Overweight

    September 7, 2026

    UN Calls for Accelerated Global Response as DRC Ebola Spreads Rapidly

    September 2, 2026

    Russian Researchers Investigate Bioactive Coatings to Enhance Titanium Implants

    August 19, 2026

    EU Allocates €2.3 Million to Enhance Africa’s Fight Against Cholera

    August 18, 2026

    Guanabenz May Slow Decline in Childhood VWM, New Study Shows

    August 17, 2026

    Congo’s Ebola crisis approaches the record for deadliest outbreak ever

    August 15, 2026

    Latest News

    Russia projects budget deficit under optimistic scenario

    September 19, 2026

    Global Gender Parity Stalls as Economic Growth Faces Sudden Slowdown

    September 19, 2026

    Bank of England Plans to Phase Out Gilt Holdings by 2034

    September 18, 2026

    Apple Launches Its First Foldable Smartphone with the iPhone Duo

    September 16, 2026

    Bank of England Reviews September Rate and Bond Policies

    September 15, 2026

    First Bird Flu Fatality Among Endangered Australian Sea Lions Reported on Kangaroo Island

    September 14, 2026

    OeNB Revises Down Austria’s 2026 Growth Forecast and Raises 2027 Outlook

    September 14, 2026

    Gold Approaches Its Lowest Level in a Week as Spot Prices Decline

    September 12, 2026
    © 2024 Buckingham Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.